CARDIAC INVOLVEMENT IN ANAPHYLAXIS
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Anaphylaxis is a severe, rapid-onset, systemic hypersensitivity reaction that can be life-threatening, especially when accompanied by cardiovascular compromise. Cardiac involvement manifesting as arrhythmia, hypotension, myocardial dysfunction, or cardiac arrest significantly increases morbidity and mortality, particularly in the pediatric population and in children with pre-existing heart disease. Anaphylaxis can result in a spectrum of cardiac effects, ranging from tachycardia and transient arrhythmias to severe cardiogenic shock, acute left ventricular dysfunction, ischemia, and Kounis syndrome (allergic myocardial infarction). Early recognition, prompt administration of intramuscular adrenaline, rapid volume replacement, and intensive care interventions including inotropic support and, in selected cases, extracorporeal life support are essential for survival and optimal outcomes. Updated international guidelines all emphasize timely adrenaline and a high index of suspicion for cardiac complications in children. Recognizing and promptly managing cardiovascular complications in anaphylaxis in children is critical. Clinicians should be familiar with the risk factors, pathophysiology, differential diagnosis, and evidence based acute intervention strategies, ensuring multidisciplinary coordination in severe/refractory cases.Anaphylaxis is a rapidly progressing, severe systemic hypersensitivity reaction that threatens life, predominantly through cardiovascular collapse, particularly in children and those with pre-existing heart disease. Beyond classic respiratory and cutaneous signs, cardiac involvement is now recognized as a major determinant of mortality and morbidity. Acute anaphylactic responses can precipitate a wide spectrum of cardiac events, ranging from compensatory sinus tachycardia and transient arrhythmias to advanced myocardial dysfunction, Kounis syndrome (allergic myocardial infarction), cardiogenic shock, and ultimately cardiac arrest. Epidemiological data reveal cardiovascular disease in up to 30% of pediatric severe cases, with higher rates in infants, adolescents, and those with underlying cardiac disease or asthma. Pathophysiology involves widespread mast cell degranulation, leading to profound vasodilation, capillary leak, and intravascular hypovolemia, further compounded by mediator-induced myocardial depression and arrhythmogenic effects. Children are especially vulnerable due to lower cardiovascular reserves and increased susceptibility to conduction abnormalities and ischemia.Clinically, early compensatory signs such as tachycardia, pallor, anxiety, and bounding pulses often evolve rapidly into hypotension, altered consciousness, cool extremities, and cyanosis. Severe progression is marked by ventricular dysfunction, life-threatening arrhythmias, bradycardia, pulseless electrical activity, and asystole. High-sensitivity cardiac biomarkers (troponin, BNP/NT-proBNP), elevated serum tryptase, and focused echocardiography are critical in diagnosis and monitoring. International guidelines unequivocally recommend immediate intramuscular adrenaline as the first-line therapy, with aggressive volume resuscitation, airway management, and advanced cardiovascular support for refractory shock. For persistent dysfunction, inotropic agents and, in select cases, extracorporeal life support (ECMO) are essential. Children with congenital or acquired heart disease require individualized approaches, emphasizing early ICU admission, echocardiographic monitoring, and neurologic surveillance. Delay in adrenaline administration is directly correlated with worse cardiac and neurologic outcomes, making early recognition and intervention vital. Multidisciplinary management and evidence-based algorithms are paramount for optimizing recovery and minimizing mortality. Future directions include early diagnostic modalities for allergic myocardial injury, improved neuroprotection strategies, and comprehensive post-arrest care protocols.Keywords: Anaphylaxis; Child; Arrhythmia; Cardiac; Myocardial stunning; Kounis syndrome
Fields of Study & Subjects
Food Allergy and Anaphylaxis Research
Drug-Induced Adverse Reactions
Mast cells and histamine
Publication details
- Journal / source
- Turkiye Klinikleri eBooks
- Pages
- 375–381
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Book chapter